Ameloblastoma of the jaws: a critical reappraisal based on a 40-years single institution experience

Oral Oncol. 2010 Jan;46(1):61-4. doi: 10.1016/j.oraloncology.2009.11.002. Epub 2009 Dec 9.

Abstract

The 40-years of experience in a single institution with the treatment of previously untreated ameloblastoma have been reported, followed by a management protocol. Retrospectively, 25 consecutive patients treated between 1969 and 2009 have been analyzed. In 11 patients, a preoperative diagnosis of ameloblastoma was available. In the remaining 14 patients the diagnosis of ameloblastoma was a postoperative one. For the recurrence rate a minimum follow-up period of 5 years was observed; 20 patients met these criteria. After primary radical surgery in five patients, no recurrences were observed. In case of conservative surgical treatment, performed in 15 patients, a recurrence was observed in eight (53%) of them. Six of these patients were then treated successfully by radical surgery, while two patients refused such surgical approach. In one of the patients with a recurrence a cervical lymph node metastasis was detected at the same time, resulting in a diagnosis of metastasizing ameloblastoma.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Ameloblastoma / epidemiology
  • Ameloblastoma / pathology*
  • Child
  • Evidence-Based Medicine
  • Female
  • Humans
  • Jaw / pathology*
  • Jaw Neoplasms / epidemiology
  • Jaw Neoplasms / pathology*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / pathology*
  • Treatment Outcome
  • Young Adult